Vorinostat in Advanced Prostate Cancer Patients Progressing on Prior Chemotherapy (NCI Trial # 6862): Trial results and IL-6 analysis. A study by the DOD Prostate Cancer Clinical Trial Consortium and University of Chicago Phase II Consortium

PURPOSE: This phase II trial was designed to evaluate the efficacy of vorinostat in chemotherapy pretreated patients with metastatic castrate resistant prostate cancer. PATIENTS AND METHODS: Patients with disease progression on one prior chemotherapy, a PSA ≥ 5ng/ml, and adequate organ function were...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Bradley, Deborah, Rathkopf, Dana, Dunn, Rodney, Stadler, Walter M., Liu, Glenn, Smith, David C., Pili, Roberto, Zwiebel, James, Scher, Howard, Hussain, Maha
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2009
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC2917101/
https://ncbi.nlm.nih.gov/pubmed/19711464
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.24597
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak